113 related articles for article (PubMed ID: 17139835)
1. [Effect of use of bone marrow cells in therapy for experimental tuberculosis].
Pospelov LE; Isaev AA; Bocharova IV; Avdienko VG; Babaian SS; Pospelov AL; Guseva AN; Gergert VIa
Probl Tuberk Bolezn Legk; 2006; (10):60-3. PubMed ID: 17139835
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis.
Cardona PJ; Amat I; Gordillo S; Arcos V; Guirado E; Díaz J; Vilaplana C; Tapia G; Ausina V
Vaccine; 2005 Feb; 23(11):1393-8. PubMed ID: 15661388
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary study on isoniazid-epiroprim combination in a tuberculosis murine model].
N'guessan K; Dosso M; Marchal G; Chavarot P; Romain F; Pescher P; Edy
Bull Soc Pathol Exot; 2002 Nov; 95(4):265-8. PubMed ID: 12596375
[TBL] [Abstract][Full Text] [Related]
4. Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B, MPT-64 and MPT-83.
Yu DH; Hu XD; Cai H
Gene Ther; 2008 May; 15(9):652-9. PubMed ID: 18288210
[TBL] [Abstract][Full Text] [Related]
5. [Examining fibrotic process in lung during treatment of chronic murine tuberculosis with lysosomotropic drug isonaizid].
Filimonov PN; Shkurupiĭ VA; Kurunov IuN; Pupyshev AB; Panasenko SG
Probl Tuberk; 1999; (1):63-5. PubMed ID: 10199191
[TBL] [Abstract][Full Text] [Related]
6. [Efficiency of anti-inflammatory therapy for experimental tuberculosis in genetically tuberculosis-sensitive mice].
Kondrat'eva TK; Rubakova EI; Evstifeev VV; Sosunov VV; Petrovskaia SN; Kondrat'eva AV; Apt AS
Probl Tuberk Bolezn Legk; 2006; (10):63-5. PubMed ID: 17139836
[TBL] [Abstract][Full Text] [Related]
7. [Experimental validation of the expediency of the use of ultra-high frequency therapy in combination with antibacterial drugs in infiltrative tuberculosis of the lungs].
Lomachenkov VD; Pavliunina LD; Bazhenov SM; Pavliunin AM; Zhamoĭdo SV
Probl Tuberk; 1989; (3):52-5. PubMed ID: 2726711
[TBL] [Abstract][Full Text] [Related]
8. [Several possibilities of organizing multimodal treatment of patients with pulmonary tuberculosis].
Savula MM; Kravchenko NS
Probl Tuberk; 2001; (8):26-8. PubMed ID: 11767385
[TBL] [Abstract][Full Text] [Related]
9. G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells.
Brunner S; Huber BC; Fischer R; Groebner M; Hacker M; David R; Zaruba MM; Vallaster M; Rischpler C; Wilke A; Gerbitz A; Franz WM
Exp Hematol; 2008 Jun; 36(6):695-702. PubMed ID: 18346841
[TBL] [Abstract][Full Text] [Related]
10. [Immunological reactivity during the pathogenetic treatment of experimental tuberculosis].
Sibirnaia RI; Snitinskaia OS
Vrach Delo; 1990 Feb; (2):77-9. PubMed ID: 2339563
[TBL] [Abstract][Full Text] [Related]
11. Prevention of the post-chemotherapy relapse of tuberculous infection by combined immunotherapy.
Buccheri S; Reljic R; Caccamo N; Meraviglia S; Ivanyi J; Salerno A; Dieli F
Tuberculosis (Edinb); 2009 Jan; 89(1):91-4. PubMed ID: 18986840
[TBL] [Abstract][Full Text] [Related]
12. Significance of haematological manifestations in patients with tuberculosis.
Singh KJ; Ahluwalia G; Sharma SK; Saxena R; Chaudhary VP; Anant M
J Assoc Physicians India; 2001 Aug; 49():788, 790-4. PubMed ID: 11837465
[TBL] [Abstract][Full Text] [Related]
13. [Postradiation life span of mice in relation to the modifying action of leukemic cells administered].
Svirnovskiĭ AI; Bakun AV; Shimanskaia TV
Radiobiologiia; 1988; 28(3):412-5. PubMed ID: 3041440
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy of tuberculosis and the immunomechanisms of the macroorganism. I. Inhibition of migration of leucocytes and the concentration of serum-immunoglobulin A in the phase of prime therapy of tuberculosis of the respiratory system (author's transl)].
Trnka L; Skvor J
Z Erkr Atmungsorgane; 1980; 155(3):267-71. PubMed ID: 6784359
[TBL] [Abstract][Full Text] [Related]
15. Mast cells modulate pulmonary acute inflammation and host defense in a murine model of tuberculosis.
Carlos D; de Souza Júnior DA; de Paula L; Jamur MC; Oliver C; Ramos SG; Silva CL; Faccioli LH
J Infect Dis; 2007 Nov; 196(9):1361-8. PubMed ID: 17922401
[TBL] [Abstract][Full Text] [Related]
16. [Immunity and resistance in experimental tuberculosis in mice exposed to various environmental factors].
Akuginova ZD; Nikonenko BV; Averbakh MM; Akuginova GE; Liashenko SM
Probl Tuberk; 1995; (1):40-3. PubMed ID: 7761381
[TBL] [Abstract][Full Text] [Related]
17. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow stem cells transplanted to the testis of sterile mice do not differentiate into spermatogonial stem cells and have no protective effect on fertility.
Van Saen D; Goossens E; De Block G; Tournaye H
Fertil Steril; 2009 Apr; 91(4 Suppl):1549-52. PubMed ID: 19006799
[TBL] [Abstract][Full Text] [Related]
19. Th1/Th2 xenogenic antibody responses are associated with recipient dendritic cells.
Kanai N; Min WP; Ichim TE; Wang H; Zhong R
Microsurgery; 2007; 27(4):234-9. PubMed ID: 17477419
[TBL] [Abstract][Full Text] [Related]
20. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
